K562 erythroleukemic cells are equipped
โ
Katrin Jurianz; Stefanie Ziegler; Natalie Donin; Yoram Reiter; Zvi Fishelson; Mi
๐
Article
๐
2001
๐
John Wiley and Sons
๐
French
โ 179 KB
Resistance of tumor cells to lysis by complement is generally attributed to several protective mechanisms. The relative impact of these mechanisms in the same tumor cell, however, has not been assessed yet. We have analyzed the interaction of the human erythroleukemia tumor cell line K562 with human